ScienceBased Health Wins Beacon Award for Innovative CD-ROM on Nutrition and Eye Health
Business Wire - November 2, 2004
CARSON CITY, Nev. -- ScienceBased Health, a leading provider of premium nutraceuticals for eye health, has just received the prestigious Beacon Award from the Northern California Business Marketing Association. The award was given for the new inte... (Read More)
Bausch & Lomb Declares Quarterly Dividend
Business Wire - November 2, 2004
ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL) today declared a regular quarterly dividend of $0.13 per share on the Common stock of the Company.
The dividend is payable Tuesday, January 4, 2005, to shareholders of record at the close of the bu... (Read More)
Tips for vibrant health and beauty at every age
Saturday Evening Post - November 1, 2004
Wear Sunglasses Year Around
During the winter months, UV rays from the sun may pose a greater threat to eye health than at any time of year. In many areas of the country, reflective surfaces such as snow and ice can increase UV exposure--and the... (Read More)
Massie Labs Brings RetCam Technology to Adult Patients With ADIS-9000; Digital Eye Imaging, Ease of Use Designed to Change Adult Eye Care
Business Wire - October 25, 2004
NEW ORLEANS -- Massie Laboratories Inc., a leading provider of integrated medical devices and services for basic eye health care, today introduced the ADIS-9000, a device that brings the company's groundbreaking RetCam technology for early detecti... (Read More)
Growing Epidemic of Wet Age-Related Macular Degeneration Ushers in New Era in Treatment of the Disease
PR Newswire - October 25, 2004
NEW ORLEANS, Oct. 25 /PRNewswire/ -- As more Americans age, the threat of blindness is increasing, and the search for new ways to prevent and treat diseases such as age-related macular degeneration (AMD) has become a high priority in the eye care... (Read More)
BI Nutraceuticals Signs Exclusive North American Distribution Deal With PIVEG for Lutein and Zeaxanthin
PR Newswire - October 22, 2004
LONG BEACH, Calif., Oct. 22 /PRNewswire/ -- Zuellig Botanicals, Inc., dba BI Nutraceuticals (BI), has partnered with Pigmentos Vegetales del Centro (PIVEG), a family-owned raw materials manufacturer based in Mexico, to be the exclusive North Amer... (Read More)
Protect Your Eyes from Spooky Contact Lenses and Dangerous Costumes, Says the Minnesota Optometric Association
Business Wire - October 19, 2004
MINNEAPOLIS -- Halloween wigs, masks and hats that obscure eyesight are just some of the real risks posed by Halloween costumes. "Cat eye," "Bloodshot," or other costume contact lenses available online and at some novelty shops... (Read More)
The Alliance Introduces Eye Care Benefit
Business Wire - October 14, 2004
MADISON, Wis. -- The Alliance employer health care cooperative now offers Wisconsin employers another reason to join: eye care health benefit plans from Ameritas Group.
Scott Bellefeuille, Alliance account executive, said adding eye care coverag... (Read More)
Bausch & Lomb Introduces Easy-to-Swallow PreserVision Soft Gels
Business Wire - October 7, 2004
ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL):
--Available in Original AREDS Formula and a Lutein Formula for Eye Health
--AREDS Formula Only Clinically Proven Eye Vitamin to Reduce Risk of Vision Loss in Age-related Macular Degeneration
B... (Read More)
Newstream.com Digest: New PreserVision Soft Gels from Bausch & Lomb, Better Health for America's 45 Million Uninsured, and Other Free Multimedia Content
Business Wire - October 7, 2004
NEW YORK -- Newstream.com Digest
Bausch & Lomb Introduces Easy-to-Swallow PreserVision(R) Soft Gels
Bausch & Lomb (NYSE:BOL) is introducing two new soft gel versions of its patented eye health nutritional supplement, PreserVision(R), o... (Read More)
Bausch & Lomb Files Patent Infringement Lawsuit Against Ocular Sciences, Inc
Business Wire - October 5, 2004
ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL) today filed a lawsuit against Ocular Sciences, Inc., of Concord, Calif., for infringement of a Bausch & Lomb patent - U.S. Patent No. 6,113,236 - that relates to toric contact lenses used to corr... (Read More)
34-Week Data Analysis from Second Clinical Trial of Bausch & Lomb's Retisert Implant for Posterior Uveitis is Presented At The Retina Society Annual
Business Wire - October 4, 2004
ROCHESTER, N.Y. -- Bausch & Lomb (NYSE: BOL)
--Implanted Eyes Showed Statistically Significant Decrease in Uveitis Recurrence Rate Post-implantation; And as Compared to Fellow Eye
--Visual Acuity Improved by At Least Three Lines in 21 Perc... (Read More)
|
